Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

85.3K
Overview
85.3K
Sex-linked Disorders01:43

Sex-linked Disorders

103.0K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
103.0K
Incomplete Dominance01:43

Incomplete Dominance

25.5K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
25.5K
Genetic Lingo01:11

Genetic Lingo

104.8K
Overview
104.8K
Pleiotropy01:33

Pleiotropy

41.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charcot-Marie-Tooth type 4 C misdiagnosed as CIDP: electrodiagnostic pitfalls and genetic confirmation.

Neurogenetics·2026
Same author

Chorea-Acanthocytosis: From Motor to Behavioral and Olfactory Profiles.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Introducing a novel variant in the FTH1 gene; A closer look at FTH1-related neuroferritinopathy as a neurodegeneration with brain iron accumulation (NBIA) disorder.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

A novel homozygous variant in the POLR1A gene: a complicated hereditary spastic paraplegia (c-HSP) or a hypomyelinating leukodystrophy type-27 (HLD27) phenotype?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

An Autosomal Dominant <i>TUBB3</i> Mutation Associated With Congenital Fibrosis of the Extraocular Muscles Type 3 in an Iranian Family.

Basic and clinical neuroscience·2026
Same journal

De Novo MFN2 p.Arg95Met in Severe Charcot-Marie-Tooth Disease Type 2A.

Journal of the peripheral nervous system : JPNS·2026
Same journal

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Journal of the peripheral nervous system : JPNS·2026
Same journal

Circulating Inflammation-Related Proteins Linked to Corneal Neuroimmune Measures, Neuropathy Deficits, and Symptoms in Type 2 Diabetes.

Journal of the peripheral nervous system : JPNS·2026
Same journal

A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis.

Journal of the peripheral nervous system : JPNS·2026
Same journal

COQ7-Related Neuropathy: Two New Cases and Review of the Literature.

Journal of the peripheral nervous system : JPNS·2026
Same journal

Health Equality and Socioeconomic Impact of Hereditary Sensory Neuropathy Type 1 (HSN1) in the UK.

Journal of the peripheral nervous system : JPNS·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.0K

GDAP1-Related Charcot-Marie-Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant

Moez Ravanbod1, Mahsa Mohammadi1, Aida Ghasemi2

  • 1Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Journal of the Peripheral Nervous System : JPNS
|July 25, 2025
PubMed
Summary
This summary is machine-generated.

Genetic analysis of 11 Iranian families identified novel GDAP1 gene variants linked to Charcot-Marie-Tooth disease. The study highlights the importance of intronic variants and suggests AD-CMT2K may be underdiagnosed due to milder symptoms.

Keywords:
Charcot–Marie‐ToothGDAP1 geneintronic variantwhole exome sequencing

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K

Related Experiment Videos

Last Updated: Sep 13, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.0K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • The GDAP1 gene is essential for mitochondrial function and its mutations cause Charcot-Marie-Tooth (CMT) disease.
  • GDAP1 mutations can lead to autosomal recessive (AR) or dominant (AD) forms of CMT.
  • Understanding GDAP1 variants is crucial for diagnosing and managing CMT subtypes.

Purpose of the Study:

  • To investigate the clinical and genetic spectrum of GDAP1-related CMT in 11 Iranian families.
  • To identify novel GDAP1 variants and characterize their inheritance patterns.
  • To evaluate the phenotypic differences between AR-CMT2K and AD-CMT2K.

Main Methods:

  • Whole exome sequencing (WES) was performed on probands from a CMT cohort.
  • Co-segregation analysis was used to validate identified GDAP1 variants.
  • Clinical data from 16 patients across 11 families were analyzed.

Main Results:

  • Eight exonic variants in GDAP1 were identified, including two novel mutations.
  • A deep intronic variant (c.311-23A>G) was found in two families, potentially indicating a founder effect in the Iranian population.
  • The c.347T>G variant, previously found in Italy, was identified in three unrelated Iranian families, suggesting it's a hotspot mutation.

Conclusions:

  • The study expands the known genetic landscape of GDAP1-related CMT, emphasizing the significance of intronic variants.
  • The c.311-23A>G variant may be a founder mutation in the Iranian population.
  • Autosomal dominant CMT type 2K (AD-CMT2K) presents a milder phenotype, potentially leading to underdiagnosis compared to other GDAP1-related CMT subtypes.